INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 158 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $158,000 | -65.7% | 11,469 | -59.4% | 0.01% | -63.2% |
Q1 2022 | $460,000 | -8.2% | 28,279 | -8.1% | 0.02% | +5.6% |
Q4 2021 | $501,000 | +61.1% | 30,780 | +47.0% | 0.02% | +80.0% |
Q3 2021 | $311,000 | -34.8% | 20,934 | -12.4% | 0.01% | -9.1% |
Q2 2021 | $477,000 | -13.4% | 23,894 | 0.0% | 0.01% | -15.4% |
Q1 2021 | $551,000 | +190.0% | 23,894 | +211.0% | 0.01% | +225.0% |
Q4 2020 | $190,000 | -44.4% | 7,683 | -7.0% | 0.00% | -50.0% |
Q3 2020 | $342,000 | +25.7% | 8,257 | +45.7% | 0.01% | +33.3% |
Q2 2020 | $272,000 | +23.1% | 5,669 | +61.8% | 0.01% | +20.0% |
Q1 2020 | $221,000 | – | 3,504 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |